• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

In vivo investigation of brain nicotine receptors using optically active radioligand

Research Project

Project/Area Number 08672474
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Physical pharmacy
Research InstitutionKYOTO UNIVERSITY

Principal Investigator

SAJI Hideo  Kyoto University, Graduate School of Pharmaceutical Sciences, Professor, 薬学研究科, 教授 (40115853)

Project Period (FY) 1996 – 1997
Project Status Completed (Fiscal Year 1997)
Budget Amount *help
¥2,500,000 (Direct Cost: ¥2,500,000)
Fiscal Year 1997: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1996: ¥2,000,000 (Direct Cost: ¥2,000,000)
KeywordsNicotine receptor / Optical isomer / Radiopharmaceutical / Brain / Alzheimer's disease / Radioreceptor assay / Biodistribution / Receptor mapping / ニコチンレセプター / レセプターアッセイ / 基底核 / インビボマッピング / キラル化合物 / 放射性探索子 / 放射性医薬品
Research Abstract

Changes in the density of nicotinic receptors have recently been reported in the brains of patients with various disorders, including Alzheimer's disease. These observations have stimulated interest in means of imaging the distribution of nicotinic receptors noninvasively in vivo with nuclear medicinal imaging techniques such as SPECT.In this study, the superior radiation properties of 123-I for SPECT promoted us to syntheszed a radioiodinated nicotine anlog iodinated at the 5-position of the pyridine, was synthesized and evaluated as a potential radioligand for investigating brain nicotine receptors by SPECT.Radioiodinated (S)-5-iodonicotine (INC) was synthsized by the radiodestannylation reaction under no-carrier-added conditions. The binding affinity of INC for brain nicotine receptors was measured in terms of displacement of 3-H-cytisine from binding sites in rat cortical membranes. The binding data revealed that the affinity of INC was the same as that of (S)-nicotine and 80-fold … More higher than that of the (R)-enatiomer. Regional cerebral distribution studies in rats by autoradiography disclosed that the accumulation of 125-I-INC was dense in the thalamus, intermediate in the cortex and striatum, and less marked in the cerebellum. 125-I-(R)-INC showed more rapid washout from the brain and less extensive regional cerebral distribution than the (S)-enatiomer. Gathered data indicate that 123-I-labeled (S)-INC is a potential radioligand for use in vivo cerebral nicotinic receptor studies by SPECT.Furthermore, the influence of inhibition of cholinergic projection on the nicotinic receptor function was investigated using quantitative autoradiography with 125-I-INC.Regional cerebral distribution of 125-I-INC was evaluated after selective inhibition of cholinergic neurons in rat basal forbrain using pyruvate dehydrogenase complex inhibitor, 3-bromopyruvic acid (BPA). In ipsilateral cortex, INC uptake increased at 6 hr post surgery and significantly decreased at 7days. The results indicate that nicotine receptor function in cerebral cortex changes after the legion of the basal forebrain. Less

Report

(3 results)
  • 1997 Annual Research Report   Final Research Report Summary
  • 1996 Annual Research Report
  • Research Products

    (10 results)

All Other

All Publications (10 results)

  • [Publications] 佐治 英郎: "^<123>I標識レセプターリガンドの開発" Radioisotopes. 45(8). 663-664 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] H.Saji: "Synthesis and characterization of radioiodinated(S)-5-iodonicotine:a new ligand for potential imaging of brain nicotinic cholinergic receptors by single photon emission computed tomography.:" Chem.Pharm.Bull.45(2). 284-290 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] H.Saji: "Synthesis,in vitro binding profile,and biodistribution of a 125-I-labeled N-benzyl pyrrolidinyl benzamide derivative:a potential radioligand for mapping dopamine D2 receptors.:" Nucl.Med.Biol.23(2). 121-127 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Hideo Saji: "Development of ligands labeled with 123-I for investigation of in vivo neuro-receptor studies." Radioisotops. 45(8). 663-664 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] H.Saji, et al: "Synthesis and characterization of radioiodinated (S)-5-iodonicotine : a new ligand for potential imaging of brain nicotinic cholinergic receptors by single photon emission computed tomography." Chem.Pharm.Bull.45(2). 284-290 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] H.Saji, et al.: "Synthesis, in vitro binding profile, and biodistribution of a ^<125>I-labeled N-benzyl pyrrolidinyl benzamide derivative : a potential radioligand for mapping dopamine D_2 receptors." Nucl.Med.Biol.23(2). 121-127 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Hideo Saji: "Synthesis and charcterization of radioiodinated (s)-5-iodonicotine:a new ligand for potential imaging of brain nicotinic cholinergic receptors by single photon emission computed tomography" Chem.Pharm.Bull.45(2). 284-290 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Hideo Saji: "Synthesis and charcterization of radioiodinated (S)-5-iodonicotine:A new ligand for potential imaging of brain nicotinic cholinergic receptors by single photon emission computed tomography" Chem.Pharm.Bull.45(2). 284-290 (1997)

    • Related Report
      1996 Annual Research Report
  • [Publications] 佐治英郎: "123-I標識レセプターリガンドの開発" Radioisotopes. 45(8). 663-664 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Hideo Saji: "Synthesis,in vivo binding profile and biodistribution of a 125-I-labeled N-benzyl pyrrolidinyl benzamide derivative:a potential radioligand for mapping dopamine D2 receptors." Nucl.Med.Biol.23(2). 121-127 (1996)

    • Related Report
      1996 Annual Research Report

URL: 

Published: 1996-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi